Goldman Sachs: China Is Beating the U.S. in the Gene Editing Arms RaceOn hot technologies like CRISPR and CAR-T, China has a leg up, Goldman says.
Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?One price watchdog group says no.
The FDA Just Approved a 2nd Revolutionary Gene Therapy. A 3rd Is Probably on the WayThe FDA approved Gilead's novel cancer-fighting gene therapy.
The Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.FDA approves Novartis treatment that reengineers human cells to kill cancer
Gilead's Deal to Buy Kite Pharma Is a Game-ChangerKite Pharma stock rose 29% on the news.
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers"I think this is the most exciting thing I have seen in my lifetime," said one FDA panel expert.
3 Key Takeaways from the World's Biggest Cancer ConferencePromising cancer drugs took center stage at ASCO 2017, which wraps up Tuesday.
Skip to Content
